In-depth trading ideas

Discover detailed market analysis from traders. See how others approach this instrument, compare different strategies, and discover perspectives that can shape your own view.

Medipharm If you can see on the chart there are many points of fvg with the priority being above a dollar. So what that tells me is the price will hit from $1 to $2 that's my price Target due to the priority FVG, AND REMEMBER EARNINGS ARE COMING OUT SOON SO BE PREPARED

by christiansmithtrades

Patience I think medipharm is a decent company they have a lot going for them and they are on the verge of profitablity, and when call you have Pierre Poilievre in office in Canada all Canadian stocks that aren't terrible are going to be bullish for sure. My average buy in is 7 cents Canadian and if your a US citizen you can literally buy way more then canadains if you have an average salary pos. My price target is 60 cents Canadian but I know this company is going to a couple of dollars here.

by christiansmithtrades

GOLDEN CROSS Today, Medipharm Labs's 50-day moving average line crossed above its 200-day moving average line, forming a GOLDEN CROSS, a STRONG BULLISH signal. Today, the stock went up by 13.33% on more than 4 times average daily volume. Tradingview's technical analysis summary is BUY: www.tradingview.com GLTA!

by IntelPowerTrader

IMMINENT GOLDEN CROSS Medipharm Labs's 50-day and 200-day moving average lines are a quarter of a penny from forming a GOLDEN CROSS, a strong BULLISH signal. Extrapolation of these lines strongly suggests that they might form a GOLDEN CROSS this coming week. Also, the Accumulation/Distribution indicator has clearly been trending upwards. Tradingview's current technical analysis summary is STRONG BUY: www.tradingview.com GLTA!

by IntelPowerTrader

POTENTIAL GOLDEN CROSS An extrapolation of MEDIPHARM LABS' 50-day and 200-day moving average lines suggests a GOLDEN CROSS should take place early next year. According to The Globe and Mail, the target price for LABS is $0.10: www.theglobeandmail.com This represents a 20% upside potential. GLTA!

by IntelPowerTrader

From 5.50 to under 0.50 stock, would you buy ?Read latest news here , here Think about stock investment like America got Talent show. If a stock has good potential but lack coverage by analysts, institutional buyers, media coverage, etc, it would take some time for investors to take notice. The show or the analysts coverage, etc are the platform that sells the company, promote its USP to the millions of investors out there who have nothing but choices of companies to invest in. Thus, someone who is able to analyse it and package it

Medif I currently do not own this stock but am looking to purchase soon for the potential run. I am no expert do your own reasearch , but im glad to share my opinion and input and learn together. Good Luck everyone! if you want to play it safe you can also ride it up to the 200dma if you keep an eye on it and sell when they meet in case of a rejection and a further drop in share price. Id say around (.73-.75)

Labs looking strong-Support and resistance level to watch Labs looking strong Support and resistance level to watch

CLIMBING ABOVE 50-DAY MOVING AVERAGE LINE Today Medipharm Labs climbed above its 50-day moving average line, a strong BULLISH signal. It did so by going up by 27.12% on more than 3 times average daily volume. In the process, it filled a major gap. TradingView's technical analysis summary is BUY: www.tradingview.com This stock has a consensus price target of $1.98: www.marketbeat.com That is more than 167.56% higher than the current price of $0.74. GLTA!

by IntelPowerTrader

This may be the bottom of LABS Looking at the weekly we can see there is a bullish divergence and there seems to be another one forming on the daily. Looks like a great recipe for a technical bottom. Of course this trade will largely depend on the earnings. breaking of this trendline would be extremely bullish and picking some up may be aggressive but extremely rewarding. with such a small current market cap this could easily 5x.I do like the management.

LABS.TO - Filled the gap. $2.50 price target from Canaccord.LABS presents a very good entry near .84 gap fill. Canaccord analyst has revised the price target to $2.50 after EU deal announcement and the company continues to produce excellent news flow. Strong support in the low .80s. Gap above at 1.69. Positive MACD divergence. Sector is finally turning bullish. I like this setup.

by agstockpicks

LABS - On serious reversal watch for descending wedge break Cannabis sector reverses this will reverse hard MM's left big gaps above that would see 3-4x return when descending wedge is broken. Low risk at these levels imo and very high reward. Currently depressed in a depressed sector that has huge growth prospects.

LABS.TO -- Oversold, Gap at $1.70 Oversold bounce play. Tested and held $1.32 for the 2nd day in a row. RSI in oversold area. Gap at $1.70.

by agstockpicks

MEDIPHARM LONG SETUP Looking at a potential low risk high reward play here. Although i pointed out the previous bull run above, I don't expect anything close to that happening at all. We are currently under a death cross and earnings are coming up, note it usually dumps at earnings after all-time-highs. This is a company I am looking at long-term though so I will buy small at this level only because of the number of opportunities in the market right now, but will essentially look out for lower prices and possible

LABS Earnings Next Week What's in store for Q4 earnings? I have no idea. I do know that I like LABS a lot. As with my other favourites, solid fundamentals and high growth potential. Fell right through my target - I ended up buying twice - and then bounced nicely. I am looking for a short term, sustained bounce towards $3.35 level, then gather some strength before moving higher again. If the broader markets continue to recover, I see LABS as a winner. If broader markets go for another round of selling, I believe my in

LABS - what happened, people?Why would a solid performer like LABS retrace close to 100%? Is this pure fear? It fell straight through my buy zone yesterday. Earnings coming up. I agree, it is a little speculative, but still?!

Long Labs Labs tested 2.71 support line back in march 2019. last support line for the sell off. Stoc indicate over sold. good timing too buy ?

$LABS - Medipharm Labs - Daily Still playing in the giant descending wedge from way back in August 2019. I am a buyer at 2.91 with a tight stop loss @ 2.80.

LABS Regression Trend| Higher Low| Key Resistance Hello Traders! Today’s chart update will be on LABS – Canadian MJ – which has been trading in a clear regression trend, close to testing upper resistance, is a break imminent? Points to consider, - Clear bear trend - Support provided by 50 MA - Regression trend resistance to break - Stochastics in lower regions - RSI respecting trend - Volume below average LABS bear trend has been putting in consecutive lower highs, with a first higher low coming to fruition, a trend change may be probab

by The_Alchemist_Trader_

Great risk to reward + time play Just a simple play in an upwards channel Only issue I have is is that there is rejection on the bottom of the channel. Taking a closer look we see some bullish divergence meaning it wants to go in. I would not enter the trade until I see it enter back into the channel and it has a nice wick on the hourly indicating clear rejection of bottom of the channel. A nice risk to reward play that can take as little as 5 days to complete!

LABS - CUP AND HANDLE LABS - Pushed through the horizontal boundary today and completed its cup and handle pattern Target - $5.38

by westcoasttrader

POSSIBLE MEDIF LONG LOOKING AT GANN FAN 2/1 HERE. SHORT TERM LONG SETUP.

Labs may be bullish next week Watch support 3.40 resistance 3.9 stop loss 3.31 Uptrend may be confirmed in the next couple weeks